Insiders Agios Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
44.69 ^USD	-1.19%		+5.00%	+100.67%

16/06	Transcript : Agios Pharmaceuticals, Inc. - Special Call
15/06	Agios Pharmaceuticals, Inc. Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress	CI

Agios Pharmaceuticals Insider Sold Shares Worth $277,397, According to a Recent SEC Filing	10/01	MT
Insider Sell: Agios Pharmaceuticals	22/23/22	MT
Insider Sell: Agios Pharmaceuticals	11/23/11	MT
Insider Sell: Agios Pharmaceuticals	01/23/01	MT
Agios Pharmaceuticals, Inc. Announces Board Changes	25/23/25	CI
Agios Pharmaceuticals, Inc. Announces Board Changes	19/23/19	CI
Insider Sell: Agios Pharmaceuticals	06/23/06	MT
Insider Sell: Agios Pharmaceuticals	16/23/16	MT
Insider Sell: Agios Pharmaceuticals	02/23/02	MT
Insider Sell: Agios Pharmaceuticals	16/23/16	MT
Insider Sell: Agios Pharmaceuticals	02/23/02	MT
Insider Sell: Agios Pharmaceuticals	20/23/20	MT
Agios Pharmaceuticals, Inc. Appoints Tsveta Milanova as Chief Commercial Officer, Effective Jan. 3, 2023	06/22/06	CI
Agios Pharmaceuticals' CFO Resigns, Replacement Named	19/22/19	MT
Agios Pharmaceuticals, Inc. Announces Resignation of Jonathan Biller as Chief Financial Officer, Effective September 16, 2022	07/22/07	CI
Agios Pharmaceuticals, Inc. Appoints Rahul Ballal and Cynthia Smith to Board of Directors	15/22/15	CI
Agios Pharmaceuticals CEO Jackie Fouse to Transition to Board Chair; Brian Goff to Take Over as CEO	13/22/13	MT
Agios Pharmaceuticals, Inc. Announces Management Changes, Effective August 8, 2022	13/22/13	CI
Agios Pharmaceuticals, Inc. Announces Chief Executive Officer Changes, Effective August 8, 2022	13/22/13	CI
Agios Pharmaceuticals, Inc. Announces Resignation of Bruce Car as Chief Scientific Officer, effective as of August 1, 2022	27/22/27	CI

No results for this search